These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4370321)

  • 1. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
    Sundsfjord JA; Marton P; Jorgensen H; Aakvaag A
    J Clin Endocrinol Metab; 1974 Oct; 39(4):734-9. PubMed ID: 4370321
    [No Abstract]   [Full Text] [Related]  

  • 2. Twenty-four year spironolactone therapy in an aged patient with aldosterone-producing adenoma.
    Takeda R; Yamazaki T; Ito Y; Koshida H; Morise T; Miyamori I; Hashimoto T; Morimoto S
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):186-90. PubMed ID: 1311894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unilateral adrenalectomy for aldosteronomas localized preoperatively by differential adrenal vein catheterization.
    Egdahl RH; Kahn PC; Melby JC
    Surgery; 1968 Jul; 64(1):117-25. PubMed ID: 5658720
    [No Abstract]   [Full Text] [Related]  

  • 4. Adrenal scintigraphy in primary aldosteronism. Preliminary report.
    Sundsfjord JA; Norman N; Jorgensen H
    Acta Med Scand; 1974; 195(1-2):15-6. PubMed ID: 4817084
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
    Ganguly A; Luetscher JA; Weinberger MH
    Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension.
    Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E
    Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537
    [No Abstract]   [Full Text] [Related]  

  • 7. [An observation of Conn's syndrome. Clinical and biological study].
    Tourniaire J; Revol A; Maret G; Blanc-Brunat N
    Rev Fr Endocrinol Clin; 1968; 9(4):333-50. PubMed ID: 4302797
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
    Vetter H; Vetter W
    Klin Wochenschr; 1975 Apr; 53(8):391-3. PubMed ID: 211313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulation by corticotropin and cortisol of aldosterone secretion in primary aldosteronism.
    Newton MA; Laragh JH
    Arch Intern Med; 1969 Feb; 123(2):147-51. PubMed ID: 4303267
    [No Abstract]   [Full Text] [Related]  

  • 10. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
    Sakamoto H; Ichikawa S; Sakamaki T; Nakamura T; Ono Z; Takayama Y; Murata K
    Am J Hypertens; 1990 Jul; 3(7):533-7. PubMed ID: 2194510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosteronism updated.
    Weinberger MH; Donohue JP
    J Urol; 1973 Jul; 110(1):1-5. PubMed ID: 4576599
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia.
    Ganguly A; Melada GA; Luetscher JA; Dowdy AJ
    J Clin Endocrinol Metab; 1973 Nov; 37(5):765-75. PubMed ID: 4356136
    [No Abstract]   [Full Text] [Related]  

  • 13. Aldosterone-producing adenoma with prolonged amelioration by dexamethasone.
    Gomi Y; Taniyama M; Ban Y; Takahashi R; Suzuki S; Murai M
    Endocr J; 2001 Jun; 48(3):331-6. PubMed ID: 11523904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary hyperaldosteronism].
    Plouin PF; Massien-Simon C
    Rev Prat; 1998 Apr; 48(7):749-53. PubMed ID: 11767370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with primary aldosteronism.
    Tremann JA; Gibbons RP; Correa RJ
    J Urol; 1973 Jul; 110(1):6-8. PubMed ID: 4713362
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical grand rounds from the University of Alabama Medical Center.
    Hardin JG; Coker AS; Blanton JH
    South Med J; 1969 May; 62(5):599-607. PubMed ID: 4305688
    [No Abstract]   [Full Text] [Related]  

  • 17. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
    Irony I; Kater CE; Biglieri EG; Shackleton CH
    Am J Hypertens; 1990 Jul; 3(7):576-82. PubMed ID: 2194512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome.
    Brown JJ; Chinn RH; Dusterdieck G; Fraser R; Lever AF; Robertson JI; Tree M
    J Endocrinol; 1969 Jan; 43(1):iv-v. PubMed ID: 5773780
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary aldosteronism.
    Biglieri EG
    Curr Ther Endocrinol Metab; 1994; 5():152-5. PubMed ID: 7704703
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.